Understanding immunological insights of liver transplantation: a practice for attaining operational tolerance.

IF 3.8 3区 医学 Q3 IMMUNOLOGY Clinical and experimental immunology Pub Date : 2025-01-21 DOI:10.1093/cei/uxae125
Geethanjali Dhayanithy, Subathra Radhakrishnan, Catherine Ann Martin, Josette Caroline Martin, Abdul Rahman Hakeem, Dinesh Jothimani, Subbaraya Narayana Kalkura, Mohamed Rela
{"title":"Understanding immunological insights of liver transplantation: a practice for attaining operational tolerance.","authors":"Geethanjali Dhayanithy, Subathra Radhakrishnan, Catherine Ann Martin, Josette Caroline Martin, Abdul Rahman Hakeem, Dinesh Jothimani, Subbaraya Narayana Kalkura, Mohamed Rela","doi":"10.1093/cei/uxae125","DOIUrl":null,"url":null,"abstract":"<p><p>Liver transplantation has been at the forefront of medical research, with efforts concentrated on understanding the intricate cellular and molecular dynamics involved this complex procedure. This body of work has chronicled critical clinical advancements, identified challenges, and highlighted progressive improvements in surgical practices. These concerted efforts have significantly contributed to the evolution and enhancement of liver transplantation, elevating it to its current level of sophistication. A successful liver transplant now demands an integrated, multidisciplinary approach that includes not only expanding the donor pool from deceased to living donors but also embracing advances in surgical methods, efficiently managing post-transplant complications, and, importantly, achieving operational tolerance. The latter, operational tolerance, is a state wherein the recipient's immune system is coaxed into accepting the transplanted organ without the long-term use of immunosuppressive drugs, thereby minimizing potential side effects, and improving quality of life. Understanding the critical immune mechanisms that aim to prevent graft rejection is essential from an immunological perspective. This review aims to highlight the crucial areas of host versus graft immune responses, making a clear distinction between organs received from living and deceased donors. It examines how these immune responses, both innate and adaptive, are initiated and proposes the exploration of molecular docking sites as a strategy to curb unwanted immune reactions. Additionally, this review explores the promising potential of biomarkers in predicting graft rejection, and emphasizes the importance of achieving tolerance and the continuous quest for innovative strategies to enhance the success and longevity of liver transplants.</p>","PeriodicalId":10268,"journal":{"name":"Clinical and experimental immunology","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11878573/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cei/uxae125","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Liver transplantation has been at the forefront of medical research, with efforts concentrated on understanding the intricate cellular and molecular dynamics involved this complex procedure. This body of work has chronicled critical clinical advancements, identified challenges, and highlighted progressive improvements in surgical practices. These concerted efforts have significantly contributed to the evolution and enhancement of liver transplantation, elevating it to its current level of sophistication. A successful liver transplant now demands an integrated, multidisciplinary approach that includes not only expanding the donor pool from deceased to living donors but also embracing advances in surgical methods, efficiently managing post-transplant complications, and, importantly, achieving operational tolerance. The latter, operational tolerance, is a state wherein the recipient's immune system is coaxed into accepting the transplanted organ without the long-term use of immunosuppressive drugs, thereby minimizing potential side effects, and improving quality of life. Understanding the critical immune mechanisms that aim to prevent graft rejection is essential from an immunological perspective. This review aims to highlight the crucial areas of host versus graft immune responses, making a clear distinction between organs received from living and deceased donors. It examines how these immune responses, both innate and adaptive, are initiated and proposes the exploration of molecular docking sites as a strategy to curb unwanted immune reactions. Additionally, this review explores the promising potential of biomarkers in predicting graft rejection, and emphasizes the importance of achieving tolerance and the continuous quest for innovative strategies to enhance the success and longevity of liver transplants.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
理解肝移植的免疫学见解:获得手术耐受的实践。
肝移植一直处于医学研究的前沿,努力集中在理解涉及这一复杂过程的复杂细胞和分子动力学。这项工作记录了关键的临床进展,确定了挑战,并强调了外科实践的进步。这些共同的努力极大地促进了肝移植的发展和增强,将其提升到目前的复杂水平。成功的肝移植现在需要一个综合的、多学科的方法,不仅包括将供体池从死者扩大到活体供体,还包括采用先进的手术方法,有效地管理移植后并发症,更重要的是,实现手术耐受。后者,即手术耐受,是指在不长期使用免疫抑制药物的情况下,诱导受者的免疫系统接受移植器官,从而最大限度地减少潜在的副作用,提高生活质量的一种状态。从免疫学的角度来看,理解旨在防止移植物排斥反应的关键免疫机制是必不可少的。本综述旨在强调宿主与移植物免疫反应的关键领域,明确区分来自活体和已故供体的器官。它研究了这些免疫反应,先天和适应性,是如何启动的,并提出了分子对接位点的探索作为一种策略来抑制不必要的免疫反应。此外,本文还探讨了生物标志物在预测移植排斥反应方面的潜力,并强调了实现耐受性和不断寻求创新策略以提高肝移植成功率和寿命的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.40
自引率
2.20%
发文量
101
审稿时长
3-8 weeks
期刊介绍: Clinical & Experimental Immunology (established in 1966) is an authoritative international journal publishing high-quality research studies in translational and clinical immunology that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice. The journal is focused on translational and clinical immunology and is among the foremost journals in this field, attracting high-quality papers from across the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through scientific studies to the treatment, prevention or diagnosis of human disease. Clinical immunology has evolved as a field to encompass the application of state-of-the-art technologies such as next-generation sequencing, metagenomics and high-dimensional phenotyping to understand mechanisms that govern the outcomes of clinical trials.
期刊最新文献
In vitro pharmacological modulation of NKG2D expression in immune cells from Behçet syndrome patients. Evolving understandings for the roles of CD38 protein in autoimmunity and autoimmune disease. An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitis. A novel fusion protein reduces kidney complement in experimental C3 glomerulopathy. Neutrophil Extracellular Traps in Rheumatoid Arthritis: Biomarkers, Drivers, and Emerging Therapeutic Targets.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1